Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Emtriva
Emtricitabine 200mg
Capsule
Gilead Sciences (NZ)
Abbott Laboratories Inc, Illinois, United States of America
Excella GmbH, Feucht, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Synacthen
Tetracosactide 0.25mg/mL equivalent to Tetracosactide hexaacetate 0.28mg/mL
Solution for injection
Novartis New Zealand Limited
Takeda Austria GmbH, Linz, Austria

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Synacthen Depot
Tetracosactide 1mg/mL equivalent to Tetracosactide hexaacetate 1.12mg/mL
Injection (depot)
Novartis New Zealand Limited
Takeda Austria GmbH, Linz, Austria

Dated this 3rd day of December 2014.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).